Related Experiment Video
Updated: Aug 6, 2026
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Cytoplasmic ERβ Localization and NTS/NTSR1 Expression in Uterine Leiomyosarcoma: An Immunohistochemical Insight
Yurena Rodríguez1, Francisco Montes de Oca2, Idaira Dorta1
1Departamento de Bioquímica, Microbiología, Biología Celular y Genética, Área de Biología Celular, Facultad de Ciencias, Sección de Biología, Universidad de La Laguna, 38200 La Laguna, Spain.
Uterine leiomyosarcoma (LMS) exhibits distinct immunohistochemical markers, including cytoplasmic estrogen receptor beta (ERβ), differing from benign leiomyomas. These findings in a single case suggest potential diagnostic insights for challenging uterine smooth muscle tumors.
Area of Science:
- Gynecologic Oncology
- Pathology
- Molecular Biology
Background:
- Uterine leiomyosarcoma (LMS) is a rare, aggressive malignancy often posing diagnostic challenges due to histological overlap with benign leiomyomas.
- Accurate differentiation is crucial for appropriate patient management and prognosis.
Purpose of the Study:
- To conduct a comparative immunohistochemical analysis of LMS, leiomyoma, and adjacent myometrium.
- To investigate potential molecular markers aiding in the diagnosis of uterine smooth muscle tumors.
Main Methods:
- Immunohistochemical analysis was performed on tissues from a patient with discordant pathological diagnoses.
- Key markers assessed included Ki67, NTS/NTSR1, and estrogen receptor beta (ERβ) subcellular localization.
Main Results:
- LMS tissue demonstrated increased Ki67 and NTS/NTSR1 expression, along with a distinct cytoplasmic localization of ERβ.
- Benign leiomyoma and normal myometrium showed predominantly nuclear ERβ localization.
- Notably, focal areas of morphologically non-neoplastic myometrium exhibited an LMS-like immunophenotype.
Conclusions:
- Subcellular localization of ERβ, NTS/NTSR1 signaling, and Ki67 expression may be associated with uterine smooth muscle tumorigenesis.
- These exploratory findings suggest potential utility in diagnosing challenging uterine smooth muscle tumors.
- Further validation in larger cohorts is warranted.
